Medicilon

Medicilon is an active, global contract research organization specializing in integrated drug discovery and preclinical development services. The company offers end-to-end solutions covering chemical synthesis, biologics, CMC development, ADME/DMPK studies, toxicology evaluations, animal modeling—including advanced oncology and metabolic disease models—and GMP-compliant API manufacturing. It supports pharmaceutical innovators worldwide from early-stage research through IND filing but does not develop its own therapeutic products or maintain an internal clinical pipeline. Its expertise includes small molecules, biologics/proteins, PROTACs technology, DNA encoded libraries, and more. The company has over two decades of experience with more than 2,400 employees across multiple global locations.